SEC Company Response from TuHURA Biosciences, (HURA) — May 12, 2015
TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: May 12, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000460
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203357
Letter
Re: DelMar Pharmaceuticals, Inc.
May 12, 2015
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC and Roth Capital Partners, LLC, as joint book running managers and representative of the underwriters, hereby request acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m., Washington D.C. time, on Wednesday May 13, 2015, or as soon thereafter as practicable.
The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:
(i) Date of preliminary prospectus: May 7, 2015
(ii) Dates of distribution: May 8 – May 11, 2015
(iii) Number of prospective underwriters and dealers to whom the preliminary prospectus was furnished: 4
(iv) Number of prospectuses so distributed: approximately 580
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
MAXIM GROUP LLC
Show Raw Text
CORRESP
1
filename1.htm
May 12, 2015
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Re: DelMar Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the
U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC and Roth Capital Partners,
LLC, as joint book running managers and representative of the underwriters, hereby request acceleration of the effective date of
the above-referenced Registration Statement so that it will become effective at 4:00 p.m., Washington D.C. time, on Wednesday May
13, 2015, or as soon thereafter as practicable.
The following is supplemental information supplied under Rule 418(a)(7)
and Rule 460 under the Securities Act of 1933:
(i)
Date of preliminary prospectus: May 7, 2015
(ii)
Dates of distribution: May 8 – May 11, 2015
(iii)
Number of prospective underwriters and dealers to whom the preliminary prospectus was furnished: 4
(iv)
Number of prospectuses so distributed: approximately 580
The undersigned confirms that it has complied with and will continue
to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply
with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
MAXIM GROUP LLC
/s/ Clifford A. Teller
_______________________________
Name: Clifford A. Teller
Title: Executive Managing Director,
Head of Investment Banking
ROTH CAPITAL PARTNERS, LLC
/s/ Aaron M. Gurewitz
_______________________________
Name: Aaron M. Gurewitz
Title: Head of Equity Capital Markets